EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy (Q30394524)

14 August 2017

EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy (English)

1 reference

14 August 2017

1 reference

19

Albrecht Bufe

1 reference

14 August 2017

31

Jan Lötvall

0 references

Victoria Cardona

Victoria Cardona

21

0 references

Gianenrico Senna

Gianenrico Senna

40

0 references

Giovanni Passalacqua

37

Giovanni Passalacqua

1 reference

14 August 2017

8

Claus Bachert

1 reference

14 August 2017

28

Marek Jutel

1 reference

14 August 2017

Aziz Sheikh

5

0 references

Cezmi Akdis

13

Cezmi Akdis

1 reference

14 August 2017

43

Marianne van Hage

1 reference

14 August 2017

29

Jörg Kleine-Tebbe

1 reference

14 August 2017

18

Barbara Bohle

1 reference

14 August 2017

24

Stephen R Durham

1 reference

14 August 2017

38

Oliver Pfaar

1 reference

14 August 2017

1

Moises A Calderon

1 reference

14 August 2017

30

Ludger Klimek

1 reference

14 August 2017

45

Ulrich Wahn

1 reference

14 August 2017

4

Jean Bousquet

1 reference

14 August 2017

14

Jocelyne Just

1 reference

14 August 2017

7

Glenis Scadding

1 reference

14 August 2017

34

Antonella Muraro

1 reference

14 August 2017

2

Pascal Demoly

1 reference

14 August 2017

35

Bodo Niggemann

1 reference

14 August 2017

3

Roy Gerth van Wijk

1 reference

14 August 2017

Anthony Frew

6

1 reference

14 August 2017

Hans J Malling

9

1 reference

14 August 2017

Rudolph Valenta

10

1 reference

14 August 2017

Beatrice Bilo

11

1 reference

14 August 2017

Antonio Nieto

12

1 reference

14 August 2017

Carmen Vidal

15

1 reference

14 August 2017

Eva M Varga

16

1 reference

14 August 2017

Emilio Alvarez-Cuesta

17

1 reference

14 August 2017

Walter G Canonica

20

1 reference

14 August 2017

Ronald Dahl

22

1 reference

14 August 2017

Alain Didier

23

1 reference

14 August 2017

Peter Eng

25

1 reference

14 August 2017

Montserrat Fernandez-Rivas

26

1 reference

14 August 2017

Lars Jacobsen

27

1 reference

14 August 2017

Carmen Moreno

32

1 reference

14 August 2017

Ralph Mosges

33

1 reference

14 August 2017

Giovanni Pajno

36

1 reference

14 August 2017

Sabina Rak

39

1 reference

14 August 2017

Gabriela Senti

41

1 reference

14 August 2017

Erkka Valovirta

42

1 reference

14 August 2017

Johannes C Virchow

44

1 reference

14 August 2017

Nikolaos Papadopoulos

46

1 reference

14 August 2017

30 October 2012

1 reference

Clinical and translational allergy

14 August 2017

1 reference

14 August 2017

2

1 reference

14 August 2017

1

1 reference

14 August 2017

20

1 reference

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients--an observational, cross sectional study in four countries in Europe

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Sublingual immunotherapy for allergic rhinitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Injection allergen immunotherapy for asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Treatment of allergic rhinitis in infants and children: efficacy and safety of second-generation antihistamines and the leukotriene receptor antagonist montelukast

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Is the prevalence of asthma declining? Systematic review of epidemiological studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

The diagnosis and management of rhinitis: an updated practice parameter

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Allergen injection immunotherapy for seasonal allergic rhinitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Effects of inhaled steroids on growth, bone metabolism, and adrenal function

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Time trends in allergic disorders in the UK.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7-year old Swiss children from 1992 to 2001.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

The allergy epidemic extends beyond the past few decades

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

The economic burden of allergic rhinitis: a critical evaluation of the literature.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Burden of allergic disease in the UK: secondary analyses of national databases

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Long-term clinical efficacy of grass-pollen immunotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3514324

Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe

20 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Dimensions of respiratory symptoms in preschool children: population-based birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Severity and impairment of allergic rhinitis in patients consulting in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Impact of asthma control on sleep, attendance at work, normal activities, and disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Maternal depression related to infant's wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Costs associated with persistent allergic rhinitis are reduced by levocetirizine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2045-7022-2-20

SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

21 January 2018

1 reference

12 December 2020

The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article

1 reference

12 December 2020

Long-term inhaled corticosteroids in preschool children at high risk for asthma

1 reference

12 December 2020

The socio-economic burden of asthma is substantial in Europe

1 reference

12 December 2020

Advances in allergen-specific immunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/2045-7022-2-20

1 reference

Dimensions Publication ID

14 August 2017

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/2045-7022-2-20

1 reference

14 August 2017

PubMed publication ID

23110958

1 reference